H. pylori is one of the most common bacterial infections in human beings, and its discovery
20 years ago altered the diagnosis and treatment of gastroduodenal disease. This review …

Background & Aims Helicobacter pylori infection is increasingly difficult to treat. The purpose
of these consensus statements is to provide a review of the literature and specific, updated …

With few exceptions, the most commonly recommended triple Helicobacter pylori regimen
(proton pump inhibitor (PPI), amoxicillin and clarithromycin) now provides unacceptably low …

Abstract Background Since the 'Fourth Chinese National Consensus Report on the
management of H. pylori infection'was published in 2012, three important consensuses …

Abstract The Asia–Pacific Consensus Conference was convened to review and synthesize
the most current information on Helicobacter pylori management so as to update the …

The K orean C ollege of H elicobacter and U pper G astrointestinal R esearch first
developed guidelines for the diagnosis and treatment of H elicobacter pylori (H. pylori) …

Helicobacter pylori (H. pylori) is a Gram-negative anaerobic bacterium that colonizes the
human stomach and is the leading cause of gastric diseases such as chronic gastritis and …

The prevalence of antimicrobial drug resistance is now so high that all patients infected with
Helicobacter pylori should be considered as having resistant infections. Ideally, therapy …

The discovery of Hellcobacter pylori has greatly changed our approach to peptic ulcer
disease. Bacterial, host, and environmental factors all have a role in peptic-ulcer disease …

Background: Antimicrobial resistance has decreased eradication rates for Helicobacter
pylori infection worldwide. Objective: To determine whether sequential treatment eradicates …